Skip to content
Open access · OA via Europe PMC

Comprehensive structure-based virtual screening of natural products enabling the discovery of new activators of SIRT1.

Bigham A, Eslami K, Sirous H, Pourfarzam M, Brogi S, Calderone V.

Research in pharmaceutical sciences · 2026

Abstract

<h4>Background and purpose</h4>Sirtuin 1 (SIRT1), a class III histone deacetylase, regulates key signaling pathways associated with health and longevity. Age-related decline in SIRT1 contributes to metabolic, inflammatory, cardiovascular, and neurodegenerative diseases. Although SIRT1-activating compounds (STACs) represent a promising therapeutic strategy, currently available activators show limited potency. This study aimed to identify novel natural SIRT1 activators using hierarchical virtual screening.<h4>Experimental approach</h4>The crystal structure of the SIRT1-resveratrol (RSV) complex was utilized to screen 46,797 natural products from the ZINC database against allosteric binding sites. Top-ranked hits were further evaluated by drug-likeness/ADMET filtering, induced-fit docking, MM-GBSA binding free energy calculations, 50 ns molecular dynamics (MD) simulations, extended 100 ns MD simulations, trajectory-based MM-GBSA analyses, and residue scanning.<h4>Findings/results</h4>Eight hits showed better docking scores than RSV. Four candidates, ZINC000005158607, ZINC000014762741, ZINC000014762739, and ZINC000005639632, exhibited stable backbone RMSD profiles (average ≤ 3.5 Å) during the initial MD simulations. Extended 100 ns simulations demonstrated stable RMSD, RMSF, and Rg profiles, together with persistent interactions involving key allosteric residues and residues of the p53-AMC peptide substrate. Trajectory-based MM-GBSA analysis identified ZINC000005158607 as the most favorable candidate (ΔG<sub>bind</sub> = -44.14 and -34.68 kcal.mol<sup>-1</sup> for site 1 and site 2, respectively), followed by ZINC000014762741 and ZINC000014762739. Residue scanning further supported ligand selectivity by confirming the energetic importance of key allosteric residues.<h4>Conclusion and implications</h4>ZINC000005158607, ZINC000014762741, and ZINC000014762739 represent promising scaffolds for developing novel SIRT1 activators and warrant further experimental validation for treating age-related diseases.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
Europe PMC
DOI
10.4103/rps.rps_232_25
Canonical
link ↗
Fetched
2026-11-12 MST

Cite this

APA
A, B., K, E., H, S., M, P., S, B., &amp; V., C. (2026). Comprehensive structure-based virtual screening of natural products enabling the discovery of new activators of SIRT1. <em>Research in pharmaceutical sciences</em>. https://doi.org/10.4103/rps.rps_232_25
Vancouver
A B, K E, H S, M P, S B, V. C. Comprehensive structure-based virtual screening of natural products enabling the discovery of new activators of SIRT1. Research in pharmaceutical sciences. 2026. doi:10.4103/rps.rps_232_25.
BibTeX
@article{bigham2026Compre, title = {Comprehensive structure-based virtual screening of natural products enabling the discovery of new activators of SIRT1.}, author = {Bigham A and Eslami K and Sirous H and Pourfarzam M and Brogi S and Calderone V.}, journal = {Research in pharmaceutical sciences}, year = {2026}, doi = {10.4103/rps.rps_232_25}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings